Abstract
Mast cells play a pivotal role in the immediate reaction in asthma. In a previous study, it was found that MicroRNA-221 (miR-221) was associated with asthma. Hence, in the present study, the role and the potential mechanisms of miR-221 on immunoglobulin E (IgE)-mediated activation of mast cells degranulation were investigated. MiR-221 expression was first quantified by qRT-PCR in IgE-mediated activation of mast cells. RBL-2H3 cells were then transfected with miR-221 mimic or miR-221 inhibitor, the IgE-mediated degranulation was detected in mast cells. The influence of miR-221 on expression of phospholipase C gamma (PLCγ1), p-PLCγ1, protein kinase B (Akt), phospho-Akt (p-Akt), inhibitor of kappa B (IκB-α), and phospho-IκB-α (p-IκB-α) were examined by Western blot, whereas free calcium ion (Ca2+) level was measured by flow cytometry and NF-κB expression was determined by EMSA. Phosphoinositide 3-kinase (PI3K)-inhibitor (LY294002) and NF-κB-inhibitor [pyrrolidine dithiocarbamate (PDTC)] were used to investigate the role of PI3K/Akt pathway and NF-κB in miR-221 promoting IgE-mediated activation of mast cells degranulation. The expression of miR-221 was upregulated in IgE-mediated activation of mast cells, and it was overexpressed in miR-221 mimic transfected cells. The degranulation was found to be significantly increased in miR-221 overexpressed cells while it was found to be significantly decreased in miR-221 downregulated cells. The expression of p-PLCγ1, p-Akt, p-IκB-α as well as NF-κB and Ca2+ release were increased in miR-221 overexpressed cells. PI3K-inhibitor (LY294002) could rescue the promotion of degranulation caused by miR-221 in IgE-mediated activation of mast cells. However, NF-κB-inhibitor (PDTC) could not rescue the promotion of degranulation caused by miR-221 in IgE-mediated activation of mast cells. MiR-221 promotes IgE-mediated activation of mast cells degranulation by PI3K/Akt/PLCγ/Ca2+ signaling pathway, in a non-NF-κB dependent manner.
Similar content being viewed by others
References
Asher MI, Montefort S, Bjorksten B, et al. (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and three repeat multicountry cross-sectional surveys[J]. Lancet 368(9537):733–743
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell 116(2):281–297
Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium signalling[J]. Nat Rev Mol Cell Biol 1(1):11–21
Biethahn K, Orinska Z, Vigorito E, et al. (2014) miRNA-155 controls mast cell activation by regulating the PI3Kgamma pathway and anaphylaxis in a mouse model[J]. Allergy 69(6):752–762
Bradding P, Walls AF, Holgate ST (2006) The role of the mast cell in the pathophysiology of asthma[J]. J Allergy Clin Immunol 117(6):1277–1284
Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation[J]. Nature 454(7203):445–454
Gottardo F, Liu CG, Ferracin M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers[J]. Urol Oncol 25(5):387–392
Kageyama-Yahara N, Wang X, Katagiri T, et al. (2011) Suppression of phospholipase Cgamma1 phosphorylation by cinnamaldehyde inhibits antigen-induced extracellular calcium influx and degranulation in mucosal mast cells[J]. Biochem Biophys Res Commun 416(3–4):283–288
Mayoral RJ, Pipkin ME, Pachkov M, et al. (2009) MicroRNA-221-222 regulate the cell cycle in mast cells[J]. J Immunol 182(1):433–445
Naal RM, Tabb J, Holowka D, et al. (2004) In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells[J]. Biosens Bioelectron 20(4):791–796
Nijboer CH, Heijnen CJ, Groenendaal F, et al. (2008) A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage[J]. Stroke 39(9):2578–2586
Perry MM, Baker JE, Gibeon DS, et al. (2014) Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma[J]. Am J Respir Cell Mol Biol 50(1):7–17
Polikepahad S, Knight JM, Naghavi AO, et al. (2010) Proinflammatory role for let-7 microRNAS in experimental asthma[J]. J Biol Chem 285(39):30139–30149
Qin HB, Xu B, Mei JJ, et al. (2012) Inhibition of miRNA-221 suppresses the airway inflammation in asthma[J]. Inflammation 35(4):1595–1599
Rivera J, Gilfillan AM (2006) Molecular regulation of mast cell activation[J]. J Allergy Clin Immunol 117(6):1214 -1225, 1226
Rodriguez A, Vigorito E, Clare S, et al. (2007) Requirement of bic/microRNA-155 for normal immune function[J]. Science 316(5824):608–611
Smith NL, Abi AD, Butcher BA, et al. (2013) Toxoplasma gondii inhibits mast cell degranulation by suppressing phospholipase Cgamma-mediated Ca(2+) mobilization[J]. Front Microbiol 4:179
Suojalehto H, Lindstrom I, Majuri ML, et al. (2014) Altered microRNA expression of nasal mucosa in long-term asthma and allergic rhinitis[J]. Int Arch Allergy Immunol 163(3):168–178
Suzuki K, Verma IM (2008) Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation[J]. Cell 134(3):485–495
Varnholt H (2008) The role of microRNAs in primary liver cancer[J]. Ann Hepatol 7(2):104–113
Zheng C, Yinghao S, Li J (2012) MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2[J]. Med Oncol 29(2):815–822
Acknowledgments
The current research was supported by National Natural Science Foundation of China (81200012; Feng Liu), National Natural Science Foundation of China (81370132; De-Yu Zhao) and Nanjing Medical Science and technique Development Foundation (Feng Liu).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Hong Xu and Li-Na Gu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xu, H., Gu, LN., Yang, QY. et al. MiR-221 promotes IgE-mediated activation of mast cells degranulation by PI3K/Akt/PLCγ/Ca2+ pathway. J Bioenerg Biomembr 48, 293–299 (2016). https://doi.org/10.1007/s10863-016-9659-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-016-9659-7